Nimblify’s Participant Payment System Makes Its Debut
Participant Payments provides clinical research sites the choice to pay participants via reloadable debit card, direct deposit or check.
Nimblify, Inc., a clinical trials technology company and wholly owned subsidiary of Forte Research Systems, has launched its first offering, a participant-centered payment system. Participant Payments provides clinical research sites the choice to pay participants via reloadable debit card, direct deposit or check, without additional work for the site. In addition to an improved patient experience, Participant Payments provides coordinators the ability to set clear expectations with participants with the help of protocol-specific guidelines, including pre-approved stipend amounts and maximums for hotel and parking reimbursements.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
June 4th 2025Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s award for almost $600 million to accelerate vaccine development will be terminated.
